The observational post-marketing study - an observational study of a drug's usage

被引：7
作者：
Meister, W
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2003年 / 128卷 / 16期
关键词：
D O I：
10.1055/s-2003-38705
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：859 / 862
页数：4
相关论文
共 12 条
[1]  
ABEL U, 1998, NONRANDOMIZED COMP C, P27
[2]   Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute? [J].
Claessens, AAMC ;
Heerdink, ER ;
van Eijk, JTM ;
Lamers, CBHW ;
Leufkens, HGM .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (08) :703-708
[3]  
EBERHARD R, 1998, ANWENDUNGSBEOBACHTUN, P93
[4]  
FEINSTEIN AR, 1998, NONRANDOMIZED COMP C, P3
[5]   Company observational post-marketing studies: drug risk assessment and drug research in special populations - a study-based analysis [J].
Hasford, J ;
Lamprecht, T .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 53 (05) :369-371
[6]   DESIGN OF DATA FORMS [J].
KNATTERUD, GL ;
FORMAN, SA ;
CANNER, PL .
CONTROLLED CLINICAL TRIALS, 1983, 4 (04) :429-440
[7]  
KORILINDNER C, 1998, ANWENDUNGSBEOBACHTUN, P11
[8]  
LINDEN M, 1998, ANWENDUNGSBEOBACHTUN, P147
[9]   EXPLANATORY AND PRAGMATIC ATTITUDES IN THERAPEUTICAL TRIALS [J].
SCHWARTZ, D ;
LELLOUCH, J .
JOURNAL OF CHRONIC DISEASES, 1967, 20 (08) :637-&
[10]   Learning versus confirming in clinical drug development [J].
Sheiner, LB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (03) :275-291
12